TEVA PHARMACEUTICAL INDUSTRIES LIMITED Notes and Loans, Noncurrent
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) had Notes and Loans, Noncurrent of $12.09 billion as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermNotesAndLoans · last filed 2026-07-29
- 2026-06-30: Notes and Loans, Noncurrent $12.09B.
- 2026-03-31: Notes and Loans, Noncurrent $14.02B.
- 2025-12-31: Notes and Loans, Noncurrent $14.99B.
- 2025-09-30: Notes and Loans, Noncurrent $16.77B.
| Period end | Notes and Loans, Noncurrent | Notes and Loans, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $12.09B 10-Q · filed 2026-07-29 | |
| 2026-03-31 | $14.02B 10-Q · filed 2026-04-29 | |
| 2025-12-31 | $14.99B 10-Q · filed 2026-07-29 | |
| 2025-09-30 | $16.77B 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $16.76B 10-Q · filed 2025-07-30 | |
| 2025-03-31 | $16.23B 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $16.00B 10-K · filed 2026-02-03 | |
| 2024-09-30 | $16.40B 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $16.55B 10-Q · filed 2024-07-31 | |
| 2024-03-31 | $16.58B 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $18.16B 10-K · filed 2025-02-05 | |
| 2023-09-30 | $18.50B 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $18.70B 10-Q · filed 2023-08-02 | |
| 2023-03-31 | $19.67B 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $19.10B 10-K · filed 2024-02-12 | |
| 2022-09-30 | $18.50B 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $20.36B 10-Q · filed 2022-07-27 | |
| 2022-03-31 | $20.84B 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $21.62B 10-K · filed 2023-02-10 | |
| 2021-09-30 | $21.04B 10-Q · filed 2021-10-27 | |
| 2021-06-30 | $21.60B 10-Q · filed 2021-07-28 | |
| 2021-03-31 | $22.29B 10-Q · filed 2021-04-28 | |
| 2020-12-31 | $22.73B 10-K · filed 2022-02-09 | |
| 2020-09-30 | $23.52B 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $24.62B 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $24.47B 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $24.56B 10-K · filed 2021-02-10 | |
| 2019-09-30 | $23.81B 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $25.95B 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $25.83B 10-Q · filed 2019-05-02 | |
| 2018-12-31 | $26.70B 10-K · filed 2020-02-21 | |
| 2018-09-30 | $26.82B 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $28.96B 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $29.45B 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $28.83B 10-K · filed 2019-02-19 | |
| 2017-09-30 | $31.97B 6-K · filed 2017-11-02 | |
| 2017-06-30 | $33.81B 6-K · filed 2017-08-03 | |
| 2017-03-31 | $32.69B 6-K · filed 2017-05-11 | |
| 2016-12-31 | $32.52B 10-K · filed 2018-02-12 | |
| 2016-09-30 | $33.18B 6-K · filed 2016-11-15 | |
| 2016-06-30 | $8.04B 6-K · filed 2016-08-04 | |
| 2016-03-31 | $8.62B 6-K · filed 2016-05-09 | |
| 2015-12-31 | $8.36B 20-F · filed 2017-02-15 | $8.38B 20-F · filed 2016-02-11 |
| 2015-09-30 | $9.52B 6-K · filed 2015-10-29 | |
| 2015-06-30 | $9.50B 6-K · filed 2015-07-30 | |
| 2015-03-31 | $9.39B 6-K · filed 2015-04-30 | |
| 2014-12-31 | $8.57B 20-F · filed 2016-02-11 | |
| 2014-09-30 | $8.82B 6-K · filed 2014-10-30 | |
| 2014-06-30 | $9.12B 6-K · filed 2014-07-31 | |
| 2014-03-31 | $10.24B 6-K · filed 2014-05-02 | |
| 2013-12-31 | $10.39B 20-F · filed 2015-02-09 | |
| 2013-09-30 | $10.06B 6-K · filed 2013-10-31 | |
| 2013-06-30 | $9.93B 6-K · filed 2013-08-01 | |
| 2013-03-31 | $9.94B 6-K · filed 2013-05-02 | |
| 2012-12-31 | $11.71B 20-F · filed 2014-02-10 | |
| 2012-09-30 | $12.69B 6-K · filed 2012-11-01 | |
| 2012-06-30 | $12.63B 6-K · filed 2012-08-02 | |
| 2012-03-31 | $10.16B 6-K · filed 2012-05-09 | |
| 2011-12-31 | $10.24B 20-F · filed 2013-02-12 | |
| 2011-09-30 | $4.37B 6-K · filed 2011-11-02 | |
| 2011-06-30 | $3.92B 6-K · filed 2011-07-28 | |
| 2011-03-31 | $4.88B 6-K · filed 2011-05-11 | |
| 2010-12-31 | $4.11B 20-F · filed 2012-02-17 | $4.10B 20-F · filed 2011-02-15 |
| 2010-09-30 | $4.73B 6-K · filed 2010-11-02 | |
| 2010-06-30 | $5.05B 6-K · filed 2010-07-27 | |
| 2009-12-31 | $3.49B 20-F · filed 2011-02-15 |